focus
Previous article:
In age of alternative facts, a scholarly course on calling out crap
Next article: Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO
Next article: Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO
hotspot
hotspot
-
Congress must protect the remaining independent doctors
2025-09-30 17:17 -
Here’s what’s in the FDA plan to include pregnant women in clinical trials
2025-09-30 17:13 -
Long Covid research funding gets a major boost from NIH
2025-09-30 17:05 -
Special counsel raises new conflict of interest concerns for De Oliveira's lawyer
2025-09-30 16:22 -
ACIP vaccine advisory panel sees its vacancies filled
2025-09-30 15:44 -
An interview with Robert F. Kennedy Jr. on vaccines
2025-09-30 15:24